Company News in the Life Science Industry

»

Reset 

Children Can be at Risk of Accidental Medicine Ingestions When Visiting Relatives This Summer

WASHINGTON, July 22, 2019 /PRNewswire/ -- The Up and Away campaign, in partnership with the Centers for Disease Control and Prevention (CDC),... Read more ››

By: PR Newswire Association LLC. - 22 Jul 2019
Related companies:  Centers for Disease Control and Prevention (CDC)

InvaGen (a Cipla Subsidiary) Receives Final Approval for Generic Version of Pfizer's Lyrica® (Pregabalin Capsules, 25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg, 300mg)

NEW YORK and MUMBAI, India, July 22, 2019 /PRNewswire/ -- InvaGen Pharmaceuticals, Inc. ("InvaGen"), a wholly-owned subsidiary of the leading global pharmaceutical company Cipla Limited (BSE: 500087; NSE: CIPLA EQ; hereafter referred to as "Cipla") announced the receipt of final approval for... Read more ››

By: PR Newswire Association LLC. - 22 Jul 2019

Sanford Guide Announces Integration with MD Labs

SPERRYVILLE, Va., July 22, 2019 /PRNewswire/ -- Sanford Guide® announces the availability of its industry-leading infectious diseases guidelines through MD Labs® Results Reports. This new integration, facilitated by Sanford Guide's content delivery API, links to pertinent Sanford Guide content... Read more ››

By: PR Newswire Association LLC. - 22 Jul 2019

2019 World Brain Day Takes Aim at Migraine

Join the World Federation of Neurology on July 22 to share "The Painful Truth" about migraine

Read more ››
By: PR Newswire Association LLC. - 22 Jul 2019

Personalized gene-edited immune cell therapy for patients with solid cancers: New data establishes approach for verifying patient-specific cancer mutation targets

SOUTH SAN FRANCISCO, Calif., July 21, 2019 /PRNewswire/ -- PACT Pharma, a leader in the fields of cancer immunology and cell therapy in collaboration with a team at UCLA, presented new data demonstrating for the first time the ability to identify mutation targets unique to each person's cancer... Read more ››

By: PR Newswire Association LLC. - 21 Jul 2019
Related companies:  PACT pharma

Oncology Venture – First day of trading in investor warrants

Read more ››
By: Nasdaq / GlobenewsWire - 21 Jul 2019

Orphazyme to prepare for filing of arimoclomol in US for Niemann-Pick disease Type C (NPC)

Read more ››
By: Nasdaq / GlobenewsWire - 21 Jul 2019
Related companies:  Orphazyme A/S

Julphar Bolsters Management Team With New Senior Appointments

- 'A key part of our strategy is ensuring we have the very best people in place,' says CEO

Read more ››
By: PR Newswire Association LLC. - 21 Jul 2019

ImCheck Therapeutics appoints Paul Frohna MD, PhD, PharmD,as Chief Medical Officer

Read more ››
By: Nasdaq / GlobenewsWire - 20 Jul 2019
Related companies:  IMCHECK THERAPEUTICS SAS

2019 World Brain Day Takes Aim at Migraine

Join the World Federation of Neurology on July 22 to share "The Painful Truth" about migraine

Read more ››
By: PR Newswire Association LLC. - 20 Jul 2019

Upsher-Smith Laboratories Completes Acquisition Of Two Treatments For Acute Migraine In Adults

MAPLE GROVE, Minn., July 20, 2019 /PRNewswire/ -- Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced... Read more ››

By: PR Newswire Association LLC. - 20 Jul 2019
Related companies:  Upsher-Smith Laboratories, LLC

Marker Therapeutics Reports Interim Results of its MultiTAA T Cell Therapy in Patients with Pancreatic Adenocarcinoma at AACR

SAN FRANCISCO, July 20, 2019 /PRNewswire/ -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage... Read more ››

By: PR Newswire Association LLC. - 20 Jul 2019
Related companies:  Marker Therapeutics, Inc

TREVENA INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL:  Kahn Swick & Foti, LLC Investigates the Officers and Directors of Trevena, Inc. - TRVN

NEW ORLEANS, July 19, 2019 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into Trevena, Inc. (NasdaqGS: TRVN).

Read more ››
By: PR Newswire Association LLC. - 20 Jul 2019
Related companies:  Trevena, Inc

Repligen Corporation Announces Closing of Public Offerings of $138.1 Million of Common Stock and $287.5 Million of 0.375% Convertible Senior Notes due 2024, Including Full Exercise of Underwriters’ Options

Read more ››
By: Nasdaq / GlobenewsWire - 20 Jul 2019
Related companies:  Repligen Corporation

Hardy Diagnostics - Automating Colony Counting

SANTA MARIA, Calif., July 19, 2019 /PRNewswire/ -- Hardy Diagnostics has designed an automated plate reader exclusively for... Read more ››

By: PR Newswire Association LLC. - 20 Jul 2019
Related companies:  Hardy Diagnostics

Audentes Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN FRANCISCO, July 19, 2019 /PRNewswire/ -- Audentes Therapeutics, Inc. (Nasdaq: BOLD), a leading AAV-based genetic medicines company focused on developing and commercializing innovative products for serious rare neuromuscular diseases, announced it has granted equity awards that were previously... Read more ››

By: PR Newswire Association LLC. - 20 Jul 2019
Related companies:  Audentes Therapeutics, Inc.

Global Healthcare Decision Support & IBM Watson Market Report, 2019 - Cognitive Computing & AI being Clubbed with Real Scientific Evidence to Promote Excellent Clinical Outcomes

DUBLIN, July 19, 2019 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 20 Jul 2019

Biohaven's Nurtec (riluzole) 505(b)2 Application for Amyotrophic Lateral Sclerosis Affected by Issues Related to Apotex Plant: Complete Response Letter (CRL) Received From FDA Related to Isolated Drug Substance Supply Used in Bioequivalence Study

NEW HAVEN, Conn., July 19, 2019 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological and neuropsychiatric diseases, today announced that it has... Read more ››

By: PR Newswire Association LLC. - 20 Jul 2019
Related companies:  Biohaven Pharmaceutical Holding Company Ltd

Compassionate Care Home Health Agency expands into Kern County

BAKERSFIELD, Calif., July 19, 2019 /PRNewswire/ -- Compassionate Care Home Health Agency, Central California's leading force in home health, announces its expansion into Bakersfield, California and is now serving all of Kern County as a part of its statewide expansion.

Read more ››
By: PR Newswire Association LLC. - 20 Jul 2019

Global Hand Hygiene Compliance Monitoring Systems Market 2016-2019 & 2026: Market Size & Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts

DUBLIN, July 19, 2019 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 20 Jul 2019
«  1  2  3  4  5  6  7  8  9  10  11 12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies